HEATHER MACADAM: Open Payments
NPI 1265411052 · AURORA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 40 payments from 13 companies in 2025. Trend: 2023 $1,011 · 2024 $806 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $244 |
| Lilly USA, LLC | 5 | $204 |
| Novo Nordisk Inc | 9 | $194 |
| ABBVIE INC. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $32 |
| Exact Sciences Corporation | 1 | $23 |
| Braeburn Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: AIRSUPRA, ZEPBOUND, Ozempic, MOUNJARO, Rybelsus, VRAYLAR, FARXIGA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
